Interventional Radiology
Online ISSN : 2432-0935
Current issue
Showing 1-3 articles out of 3 articles from the selected issue
Case Report
Original Research
  • Yasuhiro Ushijima, Yoshiki Asayama, Akihiro Nishie, Tsuyoshi Tajima, K ...
    Type: Original Research
    2019 Volume 4 Issue 1 Pages 6-13
    Published: 2019
    Released: March 15, 2019
    [Advance publication] Released: February 25, 2019
    JOURNALS OPEN ACCESS

    Purpose: To determine the prognostic factors of transcatheter arterial steroid injection therapy (TASIT) in patients with severe acute hepatic failure, with special reference to computed tomography (CT) findings.

    Material and Methods: Fifty-one patients (32 men, 19 women; mean age, 48 years) who underwent TASIT for severe acute hepatic failure at the authors' institution were enrolled. Based on patient outcomes, the patients were divided into effective and ineffective treatment groups. Attenuation of the liver parenchyma and liver volume were calculated from CT data acquired before TASIT. Miscellaneous CT findings, such as heterogeneous enhancement of the liver parenchyma, periportal edema, ascites, gall bladder wall thickening, lymphadenopathy and splenomegaly, were also evaluated. The data were compared between the groups.

    Results: The effective and ineffective treatment groups included 39 and 12 patients, respectively. All patients in the ineffective group were diagnosed with fulminant liver failure. Mean attenuation of the liver parenchyma in all patients was 44.0 Hounsfield units (HU). Mean CT value in the liver parenchyma was higher in the effective (44.7 HU) than in the ineffective (40.1 HU) treatment groups; however, the difference was not statistically significant. Of the 15 patients in whom liver parenchyma CT values were > 45 HU, all responded to TASIT. Mean liver volume and miscellaneous CT findings were not significantly different between the effective and ineffective treatment groups.

    Conclusion: Relatively preserved attenuation of the liver parenchyma may be a good prognostic factor for severe acute hepatic failure after TASIT.

    Download PDF (560K)
  • Takao Hashimoto, Tomoo Ohashi, Daisuke Watanabe, Hiroaki Namatame, Hir ...
    Type: Original Research
    2019 Volume 4 Issue 1 Pages 14-19
    Published: 2019
    Released: March 15, 2019
    JOURNALS OPEN ACCESS

    Background and purpose: Endovascular treatment for ruptured cerebral aneurysms ≤ 3 mm in diameter is controversial because it is associated with a high risk of rupture during the procedure. The aim of this study is to evaluate safety and efficacy of endovascular treatment by selecting an appropriate supporting point and shaping of microcatheter in accordance with the blood vessel running for ruptured small anterior communicating aneurysms.

    Material and Methods: Thirteen patients with ruptured small anterior communicating artery aneurysms who underwent endovascular treatment at our hospital or affiliated hospitals during the past 10 years were included. There were 3 men and 10 women, with a mean age of 69.8 (40-94) years. The mean major axis diameter was 2.5 (1.9-3.0) mm. All endovascular treatment procedures were performed by selecting an appropriate supporting point and shaping of microcatheter in accordance with the vessel running.

    Technical success rate, immediate angiographical results, periprocedural complication within 30 day, and follow-up result were retrospectively assessed.

    Results: Technical success rate was 100% (13/13). No periprocedural complication occurred. There were 4 cases of complete occlusion, 8 of neck remnant, and one of body filling. Patients were followed-up for a mean 57.3 (6-112) months, and no rebleeding or recurrent aneurysm was noted.

    Conclusions: Endovascular treatment for ruptured small anterior communicating artery by making an appropriate supporting point and shaping of microcatheter in accordance with the blood vessel running seems be safe and efficacy to prevent rebleeding of aneurysm.

    Download PDF (886K)
feedback
Top